Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Sellors JW, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: A beginners' manual. Lyon, France: International Agency for Research on Cancer, 2003.

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

CIN 3 means the full thickness of the cervical surface layer is affected by abnormal cells and if these cells are not treated, over time they may develop into cervical cancer, according to ...

Get Instant Summarized Text (Gist) A therapeutic vaccine targeting HPV16 showed promise in reducing high-grade precancerous cervical lesions in a Phase II clinical trial. Among 18 patients with ...

Cervical dysplasia is not cancer but can become cancer and spread to nearby normal tissue. There are different types of dysplasia: mild dysplasia (CIN-1), called low-grade intraepithelial lesion ...

However, it’s said that only 5 per cent of HPV infections progress to an abnormal lesion known as cervical intraepithelial neoplasia or CIN, which is a precursor to cervical cancer.